This compound is a pharmaceutical intermediate specifically used in the manufacturing process of baloxavir marboxil, an antiviral agent. It features a complex polycyclic structure containing multiple aromatic rings, halogen atoms, and stereocenters, as confirmed by analytical data.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-(hexyloxy)-3,4,12,12a-tetrahydro-, (12aR)-
pharmaceutical intermediate
Baloxavir marboxil
pharmaceutical raw material
Baloxavir
pharmaceutical raw material
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
pharmaceutical intermediate
Battery Park City Authority
pharmaceutical intermediate
2-(2-aminoethoxy)-1,1-dimethoxyethane
pharmaceutical intermediate
2-Pyridinecarboxylic acid, 1-amino-1,4-dihydro-4-oxo-3-(phenylmethoxy)-, ethyl ester
pharmaceutical intermediate
7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol
pharmaceutical intermediate
(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-phenylmethoxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione
DFYPBBJPWOUUJP-IAPPQJPRSA-N
C1COC[C@@H]2N1C(=O)C3=C(C(=O)C=CN3N2[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)OCC7=CC=CC=C7
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.